These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6094464)

  • 1. Influence of third-generation cephalosporins on aerobic intestinal flora.
    Guggenbichler JP; Kofler J
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():67-70. PubMed ID: 6094464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of third-generation cephalosporins on the aerobic intestinal flora.
    Guggenbichler JP; Kofler J; Allerberger F
    Infection; 1985; 13 Suppl 1():S137-9. PubMed ID: 4055044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cephalosporines III generation with varying biliary excretion on fecal flora and emergence of resistant bacteria during and after cessation of therapy.
    Guggenbichler JP; Allerberger FJ; Dierich M
    Padiatr Padol; 1986; 21(4):335-42. PubMed ID: 3562044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the intestinal flora of mice by parenteral treatment with broad-spectrum cephalosporins.
    van Ogtrop ML; Guiot HF; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1991 May; 35(5):976-82. PubMed ID: 1854180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bacterial resistance to the third generation cephalosporins and their clinical use.
    Kolár M; Látal T; Hájek V
    J Chemother; 1999 Aug; 11(4):260-5. PubMed ID: 10465127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single dose of cefotaxime or ceftriaxone on human faecal flora. A double-blind study.
    Michéa-Hamzehpour M; Auckenthaler R; Kunz J; Pechère JC
    Drugs; 1988; 35 Suppl 2():6-11. PubMed ID: 3396490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of cefotaxime on the intestinal bacterial ecosystem in children (author's transl)].
    Lambert-Zechovsky N; Bingen E; Proux MC; Aufrant C; Mathieu H
    Nouv Presse Med; 1981 Feb; 10(8):553-5. PubMed ID: 6259591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
    Bremner DA
    Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An analysis of bacterial resistance to antimicrobial agents in a burn centre].
    Xu W; Sun Z; Chen X
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1998 May; 14(3):199-202. PubMed ID: 10452066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1985 May; 33(5):399-403. PubMed ID: 3897972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
    Bodey GP; Fainstein V; Garcia I; Rosenbaum B; Wong Y
    J Infect Dis; 1983 Nov; 148(5):892-7. PubMed ID: 6313821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
    Baumgärtner M; Grehn M; Wundt W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of imipenem, cefotaxime and cotrimoxazole on aerobic microbial colonization of the digestive tract.
    Van der Leur JJ; Thunnissen PL; Clasener HA; Muller NF; Dofferhoff AS
    Scand J Infect Dis; 1993; 25(4):473-8. PubMed ID: 8248747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
    Willke A; Tural D
    Mikrobiyol Bul; 1987 Oct; 21(4):279-83. PubMed ID: 3332704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
    Marsh TD
    Infect Control; 1985 Feb; 6(2):78-83. PubMed ID: 3882594
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
    Norris SM; Guenthner SH; Wenzel RP
    J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethoprim resistance in South African isolates of aerobic gram-negative faecal flora.
    Adrian PV; Koornhof HJ; Wylie BA
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):916-21. PubMed ID: 8187786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.